openPR Logo
Press release

Beta-lactam and Beta-lactamase Inhibitors Market Statistics 2028 | Top Reasons for Boost the Industry

04-15-2020 12:46 PM CET | Health & Medicine

Press release from: Allied Market Research

Beta-lactam and Beta-lactamase Inhibitors Market

Beta-lactam and Beta-lactamase Inhibitors Market

Beta-lactam and Beta-lactamase Inhibitor Market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.

Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit the growth of bacteria and protozoans. The beta-lactam and beta-lactamase inhibitors market is expected to exhibit significant growth during the forecast period due to increased consumption in low and middle-income countries (LMICs) and rise in prevalence of infectious diseases. In addition, development of novel approaches for new beta-lactam and beta-lactamase inhibitors for treating bacterial infections and a large number of clinical trials, further supplement the market growth.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/5427

The beta-lactam and beta-lactamase inhibitors market is expected to exhibit significant growth during the forecast period due to the increased consumption in low- and middle-income countries (LMICs) and rise in prevalence of infectious diseases. In addition, development of novel approaches for new beta-lactam and beta-lactamase inhibitors for treating bacterial infections and a large number of clinical trials further drive the market growth. However, development of antibiotic resistance, driven by misuse of beta-lactam and beta-lactamase inhibitors and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.

Asia-Pacific was the leading revenue contributor to the global beta-lactam and beta-lactamase inhibitors market in 2018, and is expected to remain dominant throughout the forecast period. This is attributed to upsurge in incidence of chronic diseases, increase in geriatric population, rise in consumption of antibiotics, and availability of drugs over-the-counter without prescription.

The report provides a comprehensive analysis of the key players operating in the global beta-lactam and beta-lactamase inhibitors market industry, namely, Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Mylan N.V., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. The other players in the value chain include Hikma Pharmaceuticals, Melinta Therapeutics, Eli Lilly and Company, Shionogi, Inc., AstraZeneca plc, and others.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5427

Key Findings of the Beta-lactam and Beta-lactamase Inhibitor Market :
o Based on drug class, cephalosporin segment was the major revenue contributor in 2018 and is anticipated to continue this trend during the forecast period.
o Based on disease segment, its complicated intra-abdominal infection (cIAI) is expected to exhibit the highest CAGR with 4.8% during the forecast period.
o Depending on route of administration, the oral segment was the largest revenue contributor in 2018 and expected to continue this trend from 2019 to 2028.
o U.S. generated the highest revenue in the global beta-lactam and beta-lactamase inhibitors in 2018, accounting more than one-fifth of the global market in 2018.
o LAMEA is estimated to grow at a highest CAGR during the forecast period.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta-lactam and Beta-lactamase Inhibitors Market Statistics 2028 | Top Reasons for Boost the Industry here

News-ID: 2011572 • Views: 120

More Releases from Allied Market Research

Commercial Satellite Imaging Market (Updated Research Report) Growth Analysis An …
The global commercial satellite imaging market was estimated at $2.24 billion in 2018 and is expected to reach $5.25 billion by 2026, growing at a CAGR of 11.2% from 2019-2026. The report offers a detailed analysis of the drivers & opportunities, top investment pockets, top winning strategies, market size & estimations, competitive scenario, and wavering market trends. Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1751 Increasing adoption of location-based service (LBS) and rising application of
Rolling Stock Market Price, Revenue, Gross Profit, Interview Record, Business Di …
Rolling Stock Market by Product Type (Locomotives, Rapid Transit (DMU, EMU, Light Rail, Metro) Wagons, Coaches), Locomotive Propulsion (Diesel and Electric), Application (Passenger & Freight), Components: Global Opportunity Analysis and Industry Forecast, 2019-2026.” According to the report, the global rolling stock industry garnered $58.60 billion in 2018, and is expected to reach $73.8 billion by 2026, growing at a CAGR of 2.9% from 2019 to 2026. Access Full Summary @ https://www.alliedmarketresearch.com/rolling-stock-market
Safety Relay Market Growth Projections and Performance Forecast Analysis for the …
Allied Market Research published a new report, titled, "Safety Relay Market by Type (Single-Function Safety Relays and Modular & Configurable Safety Relays), Contact (Normally Closed, Time Open (NCTO), Normally Closed, Time Closed (NCTC), Normally Open, Time Open (NOTO), Normally Open, Time Closed (NOTC)) and End User (Automotive, Energy & Power, Manufacturing, Pharmaceutical, Construction, Semiconductors, and Oil & Gas): Global Opportunity Analysis and Industry Forecast, 2020–2026." The research report offers an in-depth
Investment Opportunity: Global Servo Drive Market Growing at Alarming Growth Rat …
Allied Market Research published a new report, titled, "Servo Drive Market By Type (Torque Servo, Velocity Servo, and Positioning Servo), Motor Power (Up to 1 kW, 1-2 kW, 2-5 kW, 5-15 kW, and >15 kW), Electrical Drives (DC Drive and AC Drive), Machinery (Small Equipment, Medium Machinery, and Large Machinery), and End Application (Commercial & Other Industry, Aerospace & Other Transportation Equipment, Household Appliances, Industrial Machinery, Heating Ventilating & Cooling

All 5 Releases


More Releases for Inhibitor

Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an
Global C1 Esterase Inhibitor Market Research Report
This report studies the global C1 Esterase Inhibitor market status and forecast, categorizes the global C1 Esterase Inhibitor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report CSL Behring Lev Pharmaceuticals Salix Pharmaceuticals Geographically, this report studies the top producers and consumers,
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
PAA Scale Inhibitor Market Research Report 2018
This report studies the global PAA Scale Inhibitor market status and forecast, categorizes the global PAA Scale Inhibitor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-paa-scale-inhibitor-2018-674 The major manufacturers covered in this report BASF DOW Lubrizol Arkema Nippon Shokubai Toagosei Falizan Tasfyeh THWater Shandong Xintai Water Treatment Kairui Chemical Dongfang Chemical Huanuo Runyang Chemical Friend Water
B-Cell Inhibitor Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –"B-Cell Inhibitor Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-b-cell-inhibitor-market-research-report-2017-1541200 In this report, the global B-Cell Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,